StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...

Growth Vector Analysis of Six Segments of Novartis - Case Study Example

Cite this document
Summary
Name Institution Course Date Growth Vector Analysis of six Segments of Novartis Growth Vector Analysis Chart describes a two dimension chart used in displaying a firm’s product line in respect to current and future market opportunities (Piccart 53). This chart allows for a company’s effective strategizing how they offer their products…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER97% of users find it useful
Growth Vector Analysis of Six Segments of Novartis
Read Text Preview

Extract of sample "Growth Vector Analysis of Six Segments of Novartis"

Download file to see previous pages

The term also refers to issues relating to atherosclerosis (these define diseases concerning the arterial system). Many countries around the continent have high and increasing incidents of cardiovascular diseases (Kantarjian 45). Each year, cardiovascular diseases take many American lives compared to cancer. According to Novartis, cardiovascular diseases are a significant threat and a leading cause of death to both male and female genders in most industrialized countries (Ascierto P et al 89).

In the event of these statistics, besides advocating for the importance of taking preventive measures such as decreased salt intake and avoidance of all kinds of tobacco, Novartis offers wide arrays if tools for practicing physicians for the prevention and management of the disease (WHO 33). Other ways in which Novartis tries to bring down the statistics is through the administration of prescription products which include, NeoRecormon a drug used in treating patients with anemia as a result of cancer treatment and issues relating to kidney disease (Leisinger 90).

Bezalip a lipid altering agent that is indispensable in prevention measures of cardiovascular diseases, and Torem a drug used in the treatment of renal failure, hypertension and congestive heart failure. In 2006, Novartis’ sales in drugs for the treatment of cardiovascular, related diseases accounted for 4% of the total pharmaceutical sales, a drop from 6% in 2005. The acquisition of Bezalip helped boost Novartis’ sales in 1998(Dahlgren G 42). According to the Novartis report in 2006, Bezalip was not a significant drug sale for the company as they sold it to another company and had to work on their other drugs that are NeoRecormon and Torem.

In 2001, NeoRecormon became Novartis’ best sold drug totaling to $667MM. Infective and Respiratory Segment Infective and respiratory diseases describe diseases involving virus transmission through the air or bodily fluids (R. van Tulder 32). Examples are common cold, HIV/AIDS and tuberculosis among others. The influenza virus is a crucial threat to human health as concluded by Novartis research team. Transmission of the influenza flu is through sneezing or coughing. Air molecules in the atmosphere carry the virus from one person to another thereby spreading the infectious disease.

As a result, Novartis has a prescription product referred to as Tami flu to aid in the prevention measures and treatment of the deadly virus (Kolk A 27). In reference to infectious diseases, various products are available to treat patients with Hepatitis C, HIV/AIDS and other infectious diseases. Products to treat HIV/AIDS include: Valcyte, Fuzeon, Viracept, and Fuzeon( Lipton J et al 40). Treatment for Hepatitis C is Pegasys. Other treatments for the infectious diseases include: Bactrium, Lariam, and Rocephin.

In 2006, the sale of these drugs accounted for 21% of Novartis’ sales an increase of one percent compared to 2005. The most successful sales attribute to the following drugs which include: Xolair, Tami flu, Rocephin, and Pegasys. In 2004, Tami flu fetched $302mm in sales. This was a downfall of 22% from the previous year. In 2006, Tami flu sales increased due to the increasing stockpiling of drugs in readiness of pandemics. The rise resulted to 68% increase totaling to over $2.38 billion. Oncology Segment The oncology segment deals with issues relating to cancer.

As a major player in Health Care, Novartis commits to providing the most

...Download file to see next pages Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Growth Vector Analysis of Six Segments of Novartis Case Study”, n.d.)
Growth Vector Analysis of Six Segments of Novartis Case Study. Retrieved from https://studentshare.org/business/1457096-growth-vector-analysis-of-six-segments-of-novartis
(Growth Vector Analysis of Six Segments of Novartis Case Study)
Growth Vector Analysis of Six Segments of Novartis Case Study. https://studentshare.org/business/1457096-growth-vector-analysis-of-six-segments-of-novartis.
“Growth Vector Analysis of Six Segments of Novartis Case Study”, n.d. https://studentshare.org/business/1457096-growth-vector-analysis-of-six-segments-of-novartis.
  • Cited: 0 times

CHECK THESE SAMPLES OF Growth Vector Analysis of Six Segments of Novartis

Nestle Boxed Water Production

analysis of competitors and macro environment audit will be important part of the study.... This report will do detail analysis of product portfolio and service offered by Nestle.... This report will analyze business competency of Nestle in the first section while middle section of the study will do bottled water industry analysis and final section will discuss business principles of United Kingdom.... This report will analyze business competency of Nestle in the first section while middle section of the study will do bottled water industry analysis and final section will discuss business principles of United Kingdom....
44 Pages (11000 words) Research Paper

Business Strategy and Pestle Analysis of Nestle

This essay contains the analysis of the Nestle's company business strategies.... According to the text, Nestle broadened its vision and positioned itself as nutrition, health, and Wellness Company from a food and beverage company.... hellip; The author of the essay focuses on certain factors of the Nestle's business policy....
5 Pages (1250 words) Essay

Venture Capital

Healthcare companies like novartis Venture capital division and Johnson and Johnson Development venture capital divisions earned meager amount of profits during recession.... For example the novartis venture capital division provides venture capital fund only to those companies which adhere to their corporate development plans.... South Korea is an emerging market for venture capital investments in the pharmaceutical companies hence medical companies like novartis and Johnson and Johnson have taken initiatives of providing investment to medical and life science companies who are at an early stage (novartis Venture Funds, “Our Funds”)....
5 Pages (1250 words) Research Paper

Mission Statement and Market Overview of GlaxoSmithKline Plc

Marketing Table of Contents Executive Summary 3 Mission Statement and Market Overview 4 Current market scenario 5 PESTLE analysis 6 Market share and consumers 8 SWOT Analyses 9 Segmenting, Targeting, Positioning 10 Objectives and Issues 12 Marketing Strategies 12 Marketing Programmes 13 Financial Plans 14 Metrics and Implementation Controls 14 References 16 Appendices 18 Executive Summary Pharmaceutical companies are making great contribution to the economy of United Kingdom (UK), higher than most other high-tech industries....
10 Pages (2500 words) Essay

Strategy, Business Information and Analysis

Business Information and analysis Executive Summary In order to beat competition, organisations will have to quit competing against each other.... As a result of the constant growth of local competitors, new emerging companies and decreasing demands among consumers, profit margins have become low (Hollensen, 2007).... The fundamental logic of BOS is that it provides high amount of profit growth at lower risk and is applicable to even those industries which are...
14 Pages (3500 words) Assignment

Economic Analysis of Johnson & Johnson

A detailed analysis of the economic conditions has been made.... Also to gain a better understanding of the current market an analysis of the exchange it deals To do so the details like the SIC code and the industry code have been discussed.... A detailed analysis of the financial ratios and a financial analysis have been made.... The company faces major competition from Eli Lily, novartis and Procter & Gamble.... Though novartis has comparatively lesser share of the market, Eli Lily is continuously shown steady growth over these years and has control over 20% of the market....
4 Pages (1000 words) Essay

Strategic Analysis of Pharmaceutical Sector Company - GlaxoSmithKline

It only trails Johnson & Johnson, Hoffmann La Roche, novartis, Sanofi and Pfizer.... In the year 2014, GSK was ranked number six among the world's largest pharmaceutical company.... According to Towse (2014), the growth in the market has been decelerating in the last three years....
12 Pages (3000 words) Essay

Smokers Choice

Pfizer's Nicorette is the dominant brand, with around 40% of the market, followed by GSK's NiQuitin CQ, which accounts for around a quarter of sales and novartis Nicotinell, with around a fifth (Appendix D).... The paper entitled 'Smokers Choice' presents Smokers Choice which is a new toothpaste product by Oralcare Plc....
13 Pages (3250 words) Research Paper
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us